Hydrocortisone
DrugEach subject in this group will receive one 20mg hydrocortisone capsule to be taken by mouth.
Other names: Cortef, Cortisol, Hydrocortone
NCT Number: NCT01710202
The current study will test the causal relationship between elevated levels of cortisol and the serotonin transporter gene (5-HTTLPR) as these factors influence sensitivity to environmental threat. The investigators predict that carriers of the short allele of the serotonin transporter gene who have elevated cortisol levels will be most sensitive to threatening environments, whereas carriers of the long allele who do not have elevated cortisol (placebo subjects) will be least sensitive.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University of Texas at Austin, Austin, Texas, United States
Depression vulnerability has been linked to certain variants of the serotonin transporter gene. Research indicates that a polymorphism of the serotonin transporter (5-HTTLPR) gene appears to moderate the association between life stress and depression onset. Life stress robustly predicts depression onset for individuals with two short 5-HTTLPR alleles. Individuals homozygous for the short 5-HTTLPR allele thus appear to be more sensitive to the effect of life stress, which in turn contributes to depression onset. A recent study showed that short allele carriers presented with a threat (social or other threats) who also had high levels of testosterone had elevated cortisol after exposure to the threat. There is neurobiological evidence that short allele status, elevated testosterone levels, and elevated cortisol levels are all linked to amygdala hyper-reactivity to the same classes of environmental threats. Thus, this study will test, for the first time, a potential interaction between 5-HTTLPR status and experimentally manipulated cortisol levels as risk factors for downstream mood and/or anxiety disorders by examining potential dysregulated stress responses among short allele carriers who have elevated cortisol levels.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each subject in this group will receive one 20mg hydrocortisone capsule to be taken by mouth.
Other names: Cortef, Cortisol, Hydrocortone
Time frame: 2 hours post hydrocortisone administration
Subjects will be administered hydrocortisone or placebo. One hour after administration, they will be exposed to an environmental threat manipulation. 20 minutes after this manipulation, saliva will be collected, and testosterone concentrations will be assessed and compared to pre-manipulation concentrations
University of Texas at Austin
Other
Acronym: 5-HTTLPR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT04179526
Anxiety Disorders, Behavior
Cluj-Napoca, Cluj, Romania
View Trial DetailsNCT03953014
Antidepressant Drug Adverse Reaction, Anxiety Disorders
Calgary, Alberta, Canada
View Trial DetailsNCT06763081
Antidepressant Drug Adverse Reaction, Anxiety Disorders
Winnipeg, Manitoba, Canada
View Trial Details